• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与骨纤维发育不良相关的肾单位肾痨样肾炎。

Nephronophthisis-like nephritis associated with fibrous dysplasia of bone.

作者信息

Bacchetta Justine, Chapurlat Roland, Bouvier Raymonde, Antignac Corinne, Dubourg Laurence, Kohler Rémi, Delmas Pierre D, Cochat Pierre

机构信息

Département de Pédiatrie, Centre de référence des maladies rénales rares, Hôpital Edouard-Herriot and Université Claude Bernard-Lyon 1, Lyon, France.

出版信息

Pediatr Nephrol. 2008 Sep;23(9):1559-63. doi: 10.1007/s00467-008-0850-x. Epub 2008 May 30.

DOI:10.1007/s00467-008-0850-x
PMID:18512082
Abstract

Nephronophthisis is a chronic tubulointerstitial nephritis with autosomal recessive inheritance whose evolution to end-stage renal disease is insidious but constant. Fibrous dysplasia of bone is characterized by focal replacement of normal bone and marrow with abnormal bone and fibrous tissue. We report on a young boy initially diagnosed with fibrous dysplasia of bone, who underwent renal investigation because of treatment with pamidronate. He presented with mild proteinuria (albuminuria/creatininuria 19 mg/mmol) and decreased glomerular filtration rate (GFR) (79 ml/min per 1.73 m(2) body surface area) leading to kidney biopsy, which showed nephronophthisis-like lesions, but neither NPHP1 gene deletion nor UMOD (uromodulin) mutation were identified. No association between fibrous dysplasia of bone and nephronophthisis has yet been described. Nephronophthisis-like nephritis associated with fibrous dysplasia of bone might represent a possible new syndrome in the nephronophthisis and medullary cystic kidney disease complex. However, a fortuitous association between these two conditions is also possible.

摘要

肾单位肾痨是一种常染色体隐性遗传的慢性肾小管间质性肾炎,其发展至终末期肾病的过程隐匿但持续。骨纤维发育不良的特征是正常骨和骨髓被异常骨和纤维组织局灶性替代。我们报告了一名最初被诊断为骨纤维发育不良的小男孩,他因接受帕米膦酸治疗而接受了肾脏检查。他出现轻度蛋白尿(白蛋白尿/肌酐尿为19毫克/毫摩尔)和肾小球滤过率(GFR)降低(每1.73平方米体表面积为79毫升/分钟),进而接受了肾活检,结果显示有类似肾单位肾痨的病变,但未发现NPHP1基因缺失或UMOD(尿调节蛋白)突变。尚未有骨纤维发育不良与肾单位肾痨之间关联的描述。与骨纤维发育不良相关的类似肾单位肾痨的肾炎可能代表了肾单位肾痨和髓质囊性肾病综合征中一种可能的新综合征。然而,这两种情况之间也可能是偶然关联。

相似文献

1
Nephronophthisis-like nephritis associated with fibrous dysplasia of bone.与骨纤维发育不良相关的肾单位肾痨样肾炎。
Pediatr Nephrol. 2008 Sep;23(9):1559-63. doi: 10.1007/s00467-008-0850-x. Epub 2008 May 30.
2
Fluorescence in situ hybridization for the diagnosis of NPHP1 deletion-related nephronophthisis on renal biopsy.荧光原位杂交在肾活检中诊断与 NPHP1 缺失相关的肾性尿崩症。
Hum Pathol. 2018 Nov;81:71-77. doi: 10.1016/j.humpath.2018.06.021. Epub 2018 Jun 24.
3
Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome.帕米膦酸治疗儿童及青少年McCune-Albright综合征相关性骨纤维发育不良
J Pediatr Endocrinol Metab. 2002;15 Suppl 3:929-37.
4
Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome.帕米膦酸治疗九例患有麦库恩-奥尔布赖特综合征的儿童骨纤维发育不良
Acta Paediatr. 2000 Feb;89(2):188-93. doi: 10.1080/080352500750028816.
5
Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment.静脉注射帕米膦酸治疗骨纤维异常增殖症:长期疗效及治疗反应预测因素评估
Bone. 2004 Jul;35(1):235-42. doi: 10.1016/j.bone.2004.03.004.
6
Identification of an NPHP1 deletion causing adult form of nephronophthisis.鉴定导致成人型肾单位肾痨的NPHP1基因缺失
Ir J Med Sci. 2016 Aug;185(3):589-595. doi: 10.1007/s11845-015-1312-7. Epub 2015 Jun 4.
7
Fibrous dysplasia of bone.骨纤维发育不良
Baillieres Best Pract Res Clin Rheumatol. 2000 Jun;14(2):385-98. doi: 10.1053/berh.1999.0071.
8
Treatment of monostotic fibrous dysplasia with pamidronate.帕米膦酸盐治疗单骨型纤维性骨发育不良
J Craniomaxillofac Surg. 2004 Feb;32(1):10-5. doi: 10.1016/j.jcms.2003.07.009.
9
[Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright syndrome].帕米膦酸对纤维发育不良和麦库恩-奥尔布赖特综合征临床症状及骨代谢的影响
Med Klin (Munich). 1998 Jun 15;93(6):352-9. doi: 10.1007/BF03044679.
10
Long-term effects of intravenous pamidronate in fibrous dysplasia of bone.静脉注射帕米膦酸盐对骨纤维发育不良的长期影响。
J Bone Miner Res. 1997 Oct;12(10):1746-52. doi: 10.1359/jbmr.1997.12.10.1746.

引用本文的文献

1
A human ciliopathy with polycystic ovarian syndrome and multiple subcutaneous cysts: A rare case report.一种伴有多囊卵巢综合征和多发性皮下囊肿的人类纤毛病:一例罕见病例报告。
Medicine (Baltimore). 2018 Dec;97(50):e13531. doi: 10.1097/MD.0000000000013531.

本文引用的文献

1
Fibrous dysplasia as a stem cell disease.骨纤维异常增殖症作为一种干细胞疾病。
J Bone Miner Res. 2006 Dec;21 Suppl 2:P125-31. doi: 10.1359/jbmr.06s224.
2
Differences in nephrotoxicity of intravenous bisphosphonates for the treatment of malignancy-related bone disease.静脉注射双膦酸盐治疗恶性肿瘤相关骨病时肾毒性的差异。
Onkologie. 2006 Nov;29(11):534-40. doi: 10.1159/000096056. Epub 2006 Oct 25.
3
[Nephronophtisis].[肾痨]
Nephrol Ther. 2006 Sep;2(4):200-6. doi: 10.1016/j.nephro.2006.06.006. Epub 2006 Aug 1.
4
Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenetic concept?一名转移性乳腺癌患者接受帕米膦酸治疗后出现肾病范围蛋白尿:线粒体毒性作为一种发病机制概念?
Am J Kidney Dis. 2006 Jun;47(6):1075-80. doi: 10.1053/j.ajkd.2006.02.189.
5
Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.在孤立性骨纤维发育不良中,FGF23的表达与血清磷酸盐水平相关。
Life Sci. 2006 Apr 11;78(20):2295-301. doi: 10.1016/j.lfs.2005.09.052. Epub 2005 Dec 7.
6
Fibrous dysplasia. Pathophysiology, evaluation, and treatment.骨纤维异常增殖症。病理生理学、评估与治疗。
J Bone Joint Surg Am. 2005 Aug;87(8):1848-64. doi: 10.2106/JBJS.D.02942.
7
Current pharmacological treatment for fibrous dysplasia and perspectives for the future.
Joint Bone Spine. 2005 May;72(3):196-8. doi: 10.1016/j.jbspin.2004.08.001.
8
Minireview: GNAS: normal and abnormal functions.小型综述:GNAS:正常与异常功能
Endocrinology. 2004 Dec;145(12):5459-64. doi: 10.1210/en.2004-0865. Epub 2004 Aug 26.
9
Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment.静脉注射帕米膦酸治疗骨纤维异常增殖症:长期疗效及治疗反应预测因素评估
Bone. 2004 Jul;35(1):235-42. doi: 10.1016/j.bone.2004.03.004.
10
Pamidronate-induced nephrotoxic tubular necrosis--a case report.
Clin Nephrol. 2004 Jan;61(1):63-7. doi: 10.5414/cnp61063.